We are live on ! Find out more
GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

100 hedge funds and large institutions have $699M invested in G1 Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 26 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

118% more capital invested

Capital invested by funds: $320M → $699M (+$379M)

46% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 26

0% more funds holding

Funds holding: 100 → 100 (0)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 16

14% less call options, than puts

Call options by funds: $231K | Put options by funds: $269K

Holders
100
Holders Change
–
Holders Change %
0%
% of All Funds
2.05%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
16
Increased
38
Reduced
26
Closed
16
Calls
$231K
Puts
$269K
Net Calls
-$38K
Net Calls Change
-$69K

Top Buyers

Rank Fund Capital Flow
1
CS
Candriam SCA
Luxembourg
+$8.43M
2
JP Morgan Chase
JP Morgan Chase
New York
+$5.79M
3
RJA
Raymond James & Associates
Florida
+$2.34M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$2.34M
5
BlackRock
BlackRock
New York
+$1.73M

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$6.17M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$4.12M
3
UBS AM
UBS AM
Illinois
-$3.1M
4
TCM
Tang Capital Management
California
-$1.87M
5
Morgan Stanley
Morgan Stanley
New York
-$1.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
WJWM
26
Williams Jones Wealth Management
New York
$2.95M +$1.54M +93,280 +327%
Los Angeles Capital Management
27
Los Angeles Capital Management
California
$2.94M +$995K +60,169 +98%
Two Sigma Advisers
28
Two Sigma Advisers
New York
$2.79M +$136K +8,200 +8%
Point72 Asset Management
29
Point72 Asset Management
Connecticut
$2.53M +$1.72M +104,157 New
Citadel Advisors
30
Citadel Advisors
Florida
$1.94M -$747K -45,178 -36%
Ameriprise
31
Ameriprise
Minnesota
$1.92M -$158K -9,564 -11%
California Public Employees Retirement System
32
California Public Employees Retirement System
California
$1.67M -$104K -6,262 -8%
Swiss National Bank
33
Swiss National Bank
Switzerland
$1.53M +$200K +12,100 +24%
Deutsche Bank
34
Deutsche Bank
Germany
$1.48M -$6.17M -373,059 -86%
Jacobs Levy Equity Management
35
Jacobs Levy Equity Management
New Jersey
$1.36M +$382K +23,070 +70%
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$1.33M +$116K +7,043 +15%
State of Wisconsin Investment Board
37
State of Wisconsin Investment Board
Wisconsin
$1.27M +$4.96K +300 +0.6%
AA
38
ALPS Advisors
Colorado
$1.25M -$279K -16,844 -25%
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$1.24M – – –
3C
40
361 Capital
Colorado
$1.15M -$122K -7,350 -13%
CS
41
Credit Suisse
Switzerland
$1.11M +$383K +23,159 +103%
AllianceBernstein
42
AllianceBernstein
Tennessee
$1.09M – – –
CA
43
CHI Advisors
New York
$1.07M +$728K +44,000 New
Morgan Stanley
44
Morgan Stanley
New York
$1.04M -$1.81M -109,383 -72%
PP
45
PDT Partners
New York
$993K +$677K +40,919 New
BC
46
Birchview Capital
Vermont
$970K – – –
PPA
47
Parametric Portfolio Associates
Washington
$962K +$38.9K +2,355 +6%
RJFSA
48
Raymond James Financial Services Advisors
Florida
$876K +$597K +36,122 New
Arrowstreet Capital
49
Arrowstreet Capital
Massachusetts
$859K +$585K +35,400 New
BWA
50
BDO Wealth Advisors
Florida
$855K – – –
1
2
3 4 5

GTHX Hedge Fund Activity: Q2 2020 in Review

100 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in G1 Therapeutics, Inc. Common Stock (GTHX) for Q2 2020, worth a combined $699M — up 118% from $320M a quarter earlier.

Fund positioning in GTHX was balanced in Q2 2020: 16 funds opened new positions, 16 closed out, 38 added to existing stakes and 26 trimmed.

The largest buyer was Candriam SCA, adding an estimated $8.43M. The largest seller was Deutsche Bank, cutting an estimated $6.17M.

  • 100 institutional investors held G1 Therapeutics, Inc. Common Stock (GTHX) as of Q2 2020, unchanged from Q1 2020.
  • Funds reported $699M of G1 Therapeutics, Inc. Common Stock stock for Q2 2020, up 118% quarter-over-quarter.
  • 16 funds opened new G1 Therapeutics, Inc. Common Stock positions in Q2 2020 and 16 closed out, a net change of 0 holders.
  • The largest G1 Therapeutics, Inc. Common Stock buyer in Q2 2020 was Candriam SCA, an estimated $8.43M added.
  • The largest G1 Therapeutics, Inc. Common Stock seller in Q2 2020 was Deutsche Bank, an estimated $6.17M sold.

Based on aggregated 13F filings for Q2 2020.